LublinFDReingoldSCCohenJA. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83: 278–286.
2.
WilkenJKaneRLSullivanCL. Changes in fatigue and cognition in patients with relapsing forms of multiple sclerosis treated with natalizumab: The ENER-G study. Int J MS Care2013; 15: 120–128.
3.
GoodmanADBrownTREdwardsKR. A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol2010; 68: 494–502.
4.
GoodmanADBrownTRKruppLB. Sustained-release oral fampridine in multiple sclerosis: A randomised, double-blind, controlled trial. Lancet2009; 373: 732–738.
5.
GallienPReymannJMAmarencoG. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry2005; 76: 1670–1676.
6.
KalsiVGonzalesGPopatR. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol2007; 62: 452–457.
7.
NovotnaAMaresJRatcliffeS. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol2011; 18: 1122–1131.
8.
ZajicekJPHobartJCSladeA. Multiple sclerosis and extract of cannabis: Results of the MUSEC trial. J Neurol Neurosurg Psychiatry2012; 83: 1125–1132.
9.
SedehizadehSKeoghMMaddisonP. The use of aminopyridines in neurological disorders. Clin Neuropharmacol2012; 35: 191–200.
10.
KabaySCYucelMKabayS. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: Urodynamic study. Urology2008; 71: 641–645.
11.
MinardiDMuzzonigroG. Sacral neuromodulation in patients with multiple sclerosis. World J Urol2012; 30: 123–128.
12.
VellisteMPerelSSpaldingMC. Cortical control of a prosthetic arm for self-feeding. Nature2008; 453: 1098–1101.
13.
PancrazioJJPeckhamPH. Neuroprosthetic devices: How far are we from recovering movement in paralyzed patients?Expert Rev Neurother2009; 9: 427–430.
